Published in Arch Intern Med on October 01, 1982
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature (1985) 4.66
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med (2000) 4.54
Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med (1970) 2.94
Comparison of rapid identification assays for Staphylococcus aureus. J Clin Microbiol (1984) 2.62
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med (1983) 2.17
Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems. J Clin Microbiol (1983) 2.11
Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations. Antimicrob Agents Chemother (1985) 2.02
Human small-cell lung cancers show amplification and expression of the N-myc gene. Proc Natl Acad Sci U S A (1986) 1.96
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother (1990) 1.96
Purulent pericarditis with associated cardiac tamponade caused by a Streptococcus pneumoniae strain highly resistant to penicillin, cefotaxime, and ceftriaxone. Clin Infect Dis (1998) 1.80
Beyond palliative mastectomy in inflammatory breast cancer--a reassessment of margin status. Ann Surg Oncol (1999) 1.65
Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species. Antimicrob Agents Chemother (1984) 1.40
A self-capitalization model for building behavior analysis graduate programs. Behav Anal (1995) 1.40
Shigellosis in day-care centres. Lancet (1975) 1.38
Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production. J Med Microbiol (1983) 1.29
Equating the MOS SF36 and the LSU HSI Physical Functioning Scales. J Outcome Meas (1997) 1.27
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Cancer J Sci Am (2006) 1.27
Comparison of the in vitro activity of ciprofloxacin and 24 other antimicrobial agents against clinical strains of Chromobacterium violaceum. Diagn Microbiol Infect Dis (1988) 1.26
Cefamandole therapy in anaerobic infections. Antimicrob Agents Chemother (1979) 1.22
Single-dose cefaclor therapy of urinary tract infection. Evaluation of antibody-coated bacteria test and C-reactive protein assay as predictors of cure. Am J Med (1981) 1.20
In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents. J Antimicrob Chemother (1990) 1.15
Unusual manifestations of invasive pneumococcal infection. Am J Med (1999) 1.14
Biochemistry of mammalian fertilization. Annu Rev Biochem (1974) 1.13
Skin and soft tissue infections in critical care. Crit Care Clin (1998) 1.13
Study of teaching residents how to teach. J Med Educ (1988) 1.13
Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates. J Clin Microbiol (1987) 1.13
Chronic postrheumatic-fever (Jaccoud's) arthritis. Case report with the rheumatoid factor and a family history of rheumatoid arthritis. Arch Intern Med (1967) 1.12
Histological Changes in the Rat Testis Following Heat Treatment. Yale J Biol Med (1940) 1.12
Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology. Antimicrob Agents Chemother (1990) 1.10
Evaluation of a teaching skills improvement programme for residents. Med Educ (1988) 1.09
Candidal suppurative peripheral thrombophlebitis. Ann Intern Med (1982) 1.08
Effect of some hormones on the rate of the triacylglycerol/fatty-acid substrate cycle in adipose tissue of the mouse in vivo. Biosci Rep (1983) 1.06
Fertilization of rabbit ova in a defined medium. Fertil Steril (1990) 1.04
In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline. Tubercle (1978) 1.02
Elevated mannose levels detected by gas-liquid chromatography in hydrolysates of serum from rats and humans with candidiasis. J Clin Microbiol (1982) 1.01
Role of imipenem/cilastatin in the treatment of soft tissue infections. Am J Med (1985) 1.01
Cefamandole and cefoxitin. Ann Intern Med (1985) 1.00
Management of the postmyocardial infarction patient: a consensus report--revision of 1991 CCS guidelines. Can J Cardiol (1995) 0.99
Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll Cardiol (2001) 0.99
Computerization of a hospital clinical microbiology laboratory. Am J Clin Pathol (1978) 0.99
Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria. J Antimicrob Chemother (1986) 0.98
Radiation-induced augmentation of the response of A/J mice to SaI tumor cells. Am J Pathol (1982) 0.98
Methicillin hemorrhagic cystitis. Antimicrob Agents Chemother (1977) 0.97
N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria. Antimicrob Agents Chemother (1982) 0.96
In vitro fertilization of rabbit ova. J Exp Zool (1965) 0.96
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol (1999) 0.95
Analysis of increasing antibiotic resistance of Klebsiella pneumoniae relative to changes in chemotherapy. J Infect Dis (1978) 0.95
Fatal angioedema associated with enalapril. Can J Cardiol (1989) 0.95
Vibrio vulnificus infection. Case report and update since 1970. J Am Acad Dermatol (1983) 0.94
Long-term evaluation of training residents in clinical teaching skills. J Med Educ (1986) 0.94
Myonecrosis caused by Edwardsiella tarda: a case report and case series of extraintestinal E. tarda infections. Clin Infect Dis (2001) 0.93
Unusual manifestations of pneumococcal infection in human immunodeficiency virus-infected individuals: the past revisited. Clin Infect Dis (1992) 0.93
Prosthetic valve endocarditis due to Mycobacterium chelonei. South Med J (1976) 0.92
Toxicity of Secalonic acid D. J Toxicol Environ Health (1979) 0.92
Microbiologic and antibiotic aspects of infections in the oral and maxillofacial region. J Oral Surg (1979) 0.92
Vancomycin concentration in human tissues--preliminary report. J Antimicrob Chemother (1979) 0.92
Synergism of oxacillin and gentamicin against enterococci. Antimicrob Agents Chemother (1975) 0.91
Green monkey disease ("Marburg virus" disease): a new zoonosis. Ann Intern Med (1969) 0.90
Boar acrosin. I. Purification and preliminary characterization of a proteinase from boar sperm acrosomes. J Biol Chem (1973) 0.90
Purification of a proteolytic enzyme from rabbit acrosomes. Biol Reprod (1972) 0.90
Surgical management of thyroid cancer invading the airway. Ann Surg Oncol (1997) 0.90
Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamycin-dehydropeptidase inhibitor) and cefazolin. J Antimicrob Chemother (1983) 0.89
Acrolysin, the aminoproteinase catalyzing the initial conversion of proacrosin to acrosin in mammalian fertilization. Biochem Biophys Res Commun (1976) 0.89
Fatal herpetic hepatitis in pregnancy. Obstet Gynecol (1983) 0.89
Inhibition of fertilization in vivo by pancreatic and seminal plasma trypsin inhibitors. J Reprod Fertil (1971) 0.89
Properties of a proteolytic enzyme from rabbit sperm acrosomes. Biol Reprod (1972) 0.89
In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides. Diagn Microbiol Infect Dis (1984) 0.89
Perirenal malignant Schwannoma presenting as renal cell carcinoma. Urology (1978) 0.88
Potentiation of the hepatotoxicity of carbon tetrachloride following preexposure to chlordecone (kepone) in the male rat. Toxicol Appl Pharmacol (1979) 0.87
Radiosensitivity of T and B lymphocytes. V. Effects of whole-body irradiation on numbers of recirculating T cells and sensitization to primary skin grafts in mice. Am J Pathol (1977) 0.87
Spondylitis caused by Brucella abortus. South Med J (1979) 0.87
Cardiac lesions in C mice. Result of choline-deficient and choline-supplemented diets. Arch Pathol (1968) 0.87
Pulmonary capillary hemangiomatosis-like foci. An autopsy study of 8 cases. Am J Clin Pathol (2000) 0.87
Purification and properties of aryl sulfatases from rabbit sperm acrosomes. Proc Soc Exp Biol Med (1974) 0.86
Improved utilization of the surgical suite. Hospitals (1971) 0.86
Spontaneous and dietary-induced cardiovascular lesions in DBA mice. Anat Rec (1965) 0.86
Photodynamic therapy for corneal neovascularisation and lipid degeneration. Br J Ophthalmol (2004) 0.86
Moxalactam in the therapy of serious infections. Antimicrob Agents Chemother (1982) 0.86
Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia. Arch Intern Med (1984) 0.86
Comparison of clinical and treadmill variables for the prediction of outcome after myocardial infarction. J Am Coll Cardiol (1984) 0.85
Brain abscess caused by Cladosporium trichoides (Bantianum): a case with paranasal sinus involvement. South Med J (1976) 0.84
Metronidazole in the treatment of anaerobic infections. Am Rev Respir Dis (1979) 0.84
Relationship of a trypsin-like enzyme in rabbit spermatozoa to capacitation. J Reprod Fertil (1969) 0.84
Dietary-induced atrial thrombosis in mice. Arch Pathol (1965) 0.84
Observations on the induction of ovulation and fertilization in vitro in the squirrel monkey (Saimiri sciureus). Fertil Steril (1973) 0.84
Piperacillin v Carbenicillin in the therapy for serious infections. Arch Intern Med (1982) 0.83
Cat-scratch disease causing reversible encephalopathy. JAMA (1978) 0.83